Data / Drug companies / Ciprofloxacin and dexamethasone
Ciprofloxacin and dexamethasone: 12 companies and 14 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Ciprofloxacin and dexamethasone is listed in the FDA National Drug Code Directory by 12 companies, with 14 products in commercial distribution. 13 of the products (92.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are suspension/ drops, and the newest product started marketing on October 15, 2026.
The request: Get every company that lists ciprofloxacin and dexamethasone in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 14
- Generic (ANDA) products
- 13 (92.9%)
- Application numbers
- 6
- Routes
- Auricular (otic)
- openFDA record search
- api.fda.gov
Companies that list ciprofloxacin and dexamethasone
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 2 | suspension/ drops | Generic drugs (ANDA) | September 1, 2022 |
| Redpharm Drug | 2 | suspension/ drops | Generic drugs (ANDA) | November 1, 2023 |
| Alembic Pharmaceuticals Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | October 15, 2026 |
| Alembic Pharmaceuticals Limited | 1 | suspension/ drops | Generic drugs (ANDA) | October 15, 2026 |
| Amneal Pharmaceuticals of New York LLC | 1 | suspension/ drops | Generic drugs (ANDA) | March 26, 2024 |
| Armas Pharmaceuticals Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | November 1, 2023 |
| Dr. Reddy's Laboratories Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | August 10, 2020 |
| NorthStar Rx LLC | 1 | suspension/ drops | Generic drugs (ANDA) | August 1, 2022 |
| Sandoz Inc | 1 | suspension/ drops | Authorized generics (NDA) | August 10, 2020 |
| Sentiss Pharmaceuticals LLC | 1 | suspension/ drops | Generic drugs (ANDA) | April 16, 2026 |
| Sportpharm LLC | 1 | suspension/ drops | Generic drugs (ANDA) | August 10, 2020 |
| Sun Pharmaceutical Industries, Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | September 1, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Suspension/ drops | 14 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 13 | 92.9% |
| Authorized generics (NDA) | 1 | 7.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Corticosteroid | 14 |
| Fluoroquinolone Antibacterial | 14 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.